Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02135679 · ClinicalTrials.gov registry record
The Detection Of Circulating Tumor Cells (CTC) In Patients With NSCLC Undergoing Definitive Radiotherapy Or Chemoradiotherapy
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 204
- Enrollment target
NCT02135679 is a clinical trial that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 204 participants.
The verdict
NCT02135679 has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 204 participants
- Enrollment target
Study Summary
CTC levels collected pre-surgery will be correlated with pathological samples.
Interventions
- RADIATION Radiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2012-09 |
| Est. Completion | 2021-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02135679
The ClinicalTrials.gov registry entry for NCT02135679 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radiotherapy is the first listed.
NCT02135679 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02135679 about?
NCT02135679 is a clinical study titled "The Detection Of Circulating Tumor Cells (CTC) In Patients With NSCLC Undergoing Definitive Radiotherapy Or Chemoradiotherapy". CTC levels collected pre-surgery will be correlated with pathological samples.
What is the current status of trial NCT02135679?
This trial is currently completed. The enrollment target is 204 participants. The study started on 2012-09. Estimated completion is 2021-12.
What interventions are being tested in trial NCT02135679?
The interventions under investigation include: Radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT02135679?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.